Home > Healthcare > Medical Devices > Implantable Devices > ocular implants market
Get a free sample of Ocular Implants Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Ocular Implants Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The global ocular implants market size was valued at USD 17.1 billion in 2024 and is expected to exhibit growth at a CAGR of 6.4% from 2025 to 2034. High market growth can be attributed to the increasing demand for aesthetic solutions, rising adoption of minimally invasive procedures, escalating healthcare spending, and the growing aging population, among other contributing factors.
Moreover, the rising prevalence of eye disorders such as cataracts, glaucoma, and macular degeneration is a key driver for the ocular implants market. For instance, according to the World Health Organization (WHO), over 2.2 billion people globally have vision impairments. Similarly, the National Eye Institute projects that cataract cases in the U.S. will increase from 37.2 million in 2022 to 50 million by 2050. Factors such as aging populations, digital eye strain, and environmental risks are further increasing the demand for ocular implants, while advancements in ophthalmology and early diagnosis continue to drive the need for effective surgical solutions.
Furthermore, increasing awareness of cosmetic ocular options is fueling growth in the aesthetic segment of the market. Artificial iris implants and custom-designed ocular prosthetics are attracting patients seeking solutions for congenital conditions, trauma, or disfigurement. These individuals are turning to ocular implants to improve their appearance and boost their confidence.
Ocular implants are medical devices surgically placed in or around the eye to restore or enhance visual function, support damaged ocular structures, or improve aesthetic appearance. These implants include intraocular lenses (IOLs) for cataract treatment, corneal implants for vision correction, and orbital implants for reconstructive purposes.
Key players in the ocular implants industry include AbbVie, Alcon, Bausch Health, Glaukos Corporation, Gulden Ophthalmics, HOYA Corporation, HumanOptics Holding, Johnson & Johnson, Lenstec, MORCHER, NIDEK, and Orbtex.
The U.S. ocular implants market generated USD 6.4 billion in revenue in 2024 and is anticipated to grow at a 6.1% CAGR from 2025 to 2034, driven by the high prevalence of age-related eye disorders.
The glaucoma implants segment is expected to grow at a CAGR of 6.2%, reaching over USD 12.1 billion by 2034, fueled by the rising prevalence of glaucoma due to aging populations and longer life expectancy.
The global ocular implants industry was valued at USD 17.1 billion in 2024 and is projected to grow at a 6.4% CAGR from 2025 to 2034, driven by increasing demand for aesthetic solutions and minimally invasive procedures.